Hospital General Universitario de Elche Servicio de Farmacia
About Hospital General Universitario de Elche Servicio de Farmacia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital General Universitario de Elche Servicio de Farmacia
During the past decade, Hospital General Universitario de Elche Servicio de Farmacia conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
2001-03-01
2008-11-01
Completed
S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
2006-04-01
Unknown status
500
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
2005-07-01
2021-12-13
Completed
6,927
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
2013-07-01
2014-06-01
Terminated
18
Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
2014-01-01
2019-12-01
Completed
310
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario de Elche Servicio de Farmacia"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hospital General Universitario de Elche Servicio de Farmacia
According to Clinical.Site data, the most researched conditions in "Hospital General Universitario de Elche Servicio de Farmacia" are
"Alzheimer's Disease" (1 trials), "Bone Metastasis" (1 trials) and "Cancer Pain" (1 trials). Many other conditions were trialed in "Hospital General Universitario de Elche Servicio de Farmacia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital General Universitario de Elche Servicio de Farmacia
Most popular intervention types in "Hospital General Universitario de Elche Servicio de Farmacia" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Donepezil" (1 trials), "Galantamine" (1 trials), "Memantine" (1 trials), "Placebo" (1 trials) and "RO4602522" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital General Universitario de Elche Servicio de Farmacia
The vast majority of trials in "Hospital General Universitario de Elche Servicio de Farmacia" are
2 trials for "All" genders.
Clinical Trials Status at Hospital General Universitario de Elche Servicio de Farmacia
Currently, there are NaN active trials in "Hospital General Universitario de Elche Servicio de Farmacia".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hospital General Universitario de Elche Servicio de Farmacia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General Universitario de Elche Servicio de Farmacia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".